Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Does the need for early cutaneous vesicostomy correlate with poor urinary outcomes in girls with cloacal malformation?

Journal of pediatric surgery·2026

Same author

Association of small intestinal atresia and Hirschsprung disease in a multi-institutional colorectal registry.

Journal of pediatric surgery·2026

Same author

Impact of Trisomy 21 on post pull-through enterocolitis and bowel function in children with Hirschsprung disease: A PCPLC analysis.

Journal of pediatric surgery·2026

Same author

Beyond the pull-through: A multi-institutional study of long-term surgical and functional outcomes in total colonic hirschsprung disease - A pediatric colorectal and pelvic learning consortium (PCPLC) study.

Journal of pediatric surgery·2026

Same author

Feasibility and accuracy of using pediatric health information system to study Hirschsprung disease outcomes in the ICD-10 era.

Journal of pediatric surgery·2026

Same author

Validation of an anorectal malformation trainer - Can a high-fidelity model simulate real life?

Journal of pediatric surgery·2026

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Update on vitamin D and type 2 diabetes.

Christy S Maxwell¹, Richard J Wood

¹Department of Nutrition, University of Massachusetts, Amherst, Massachusetts, USA.

Nutrition Reviews

|April 28, 2011

Summary

Vitamin D supplementation shows no conclusive link to preventing type 2 diabetes or improving glucose intolerance. Further research is needed to understand its effects on insulin resistance, particularly in deficient individuals.

Area of Science:

Endocrinology
Nutritional Science
Metabolic Disorders

Background:

Type 2 diabetes mellitus (T2DM) prevalence is rising globally, linked to obesity.
Modifiable lifestyle factors including exercise, diet (e.g., vitamin D deficiency), alcohol, and smoking influence T2DM pathogenesis.
Observational studies suggest a role for vitamin D, but intervention trial data is inconclusive.

Purpose of the Study:

To evaluate the evidence for vitamin D supplementation's impact on type 2 diabetes risk and glucose metabolism.
To identify gaps in current research regarding vitamin D and diabetes.
To propose optimal trial designs for future investigations.

Main Methods:

Review and pooling of data from vitamin D intervention trials.

Related Experiment Videos

Last Updated: Jun 2, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Analysis of effects on diabetes risk, glucose intolerance, and insulin resistance.

Identification of limitations in existing study designs.

Main Results:

Pooled data from vitamin D intervention trials lack conclusive evidence for preventing T2DM or improving glucose intolerance.
A potential effect of vitamin D on insulin resistance may exist, but requires further investigation.
Current trials are insufficient to draw definitive conclusions.

Conclusions:

Vitamin D supplementation does not currently have conclusive evidence supporting its role in preventing type 2 diabetes or improving glucose intolerance.
Well-designed trials are necessary to investigate vitamin D's effects on intermediate diabetes biomarkers.
Future studies should focus on insulin-resistant individuals with low baseline vitamin D levels (< 50 nmol/L) and aim for sufficient supplementation to reach levels > 75 nmol/L.